Your browser doesn't support javascript.
loading
Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamics.
Wang, Rui-Rui; Liu, Wen-Shan; Zhou, Liang; Ma, Ying; Wang, Run-Ling.
Afiliación
  • Wang RR; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.
  • Liu WS; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.
  • Zhou L; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.
  • Ma Y; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.
  • Wang RL; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.
J Biomol Struct Dyn ; 38(5): 1525-1538, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31043123

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína Tirosina Fosfatasa no Receptora Tipo 11 / Simulación de Dinámica Molecular Idioma: En Revista: J Biomol Struct Dyn Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína Tirosina Fosfatasa no Receptora Tipo 11 / Simulación de Dinámica Molecular Idioma: En Revista: J Biomol Struct Dyn Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido